BRISTOL-MYERS SQUIBB COMPANY group: subsidiaries and structure
Corporation · WILMINGTON, United States · LEI HLYYNH7UQUORYSJQCN42
26subsidiaries
17countries
5held directly
18lapsed LEIs
22links on accounts older than 24 months
4ISINs of subsidiaries
Summary
BRISTOL-MYERS SQUIBB COMPANY is the ultimate parent of 26 subsidiaries with LEIs in 17 countries, as reported to GLEIF. 5 are held directly; the others sit below intermediate companies. The largest numbers are in the United States (5), in Ireland (4) and in Switzerland (2). 18 of the subsidiaries have a lapsed LEI, and 22 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 978 ISINs for the parent and 4 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
and 2 more
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
23 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
BMS FOREX COMPANY United States
BMS STRATEGIC PORTFOLIO INVESTMENTS HOLDINGS, INC. United States
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Australia Pty Ltd | Australia | Melbourne | 549300G175P55OU5SZ71 | 2016 | lapsed > 24 months |
| BRISTOL - MYERS SQUIBB BELGIUM | Belgium | BRUSSELS | 549300DIUW89K7HPUN77 | 2020 | lapsed > 24 months |
| Bristol-Myers Squibb Canada Co. | Canada | Halifax | 549300695EJW7MQQ3Y38 | 2016 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB SA | Switzerland | STEINHAUSEN | 5493000OZC4SYTEBVO64 | 2016 | lapsed > 24 months |
| WESTWOOD-INTRAFIN SA | Switzerland | CHAM | 549300TLGN00JT18WP38 | 2017 | lapsed > 24 months |
| Bristol-Myers Squibb GmbH & Co. KGaA | Germany | München | 549300NQHRQ8HVPTAK20 | 2024 | |
| Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH | Germany | München | 529900UUYOIQ87RNV696 | 2023 | > 24 months |
| BRISTOL MYERS SQUIBB S.A. | Spain | MADRID | 549300NC2NBTWMJ63T10 | 2024 | lapsed |
| Oy Bristol-Myers Squibb (Finland) Ab | Finland | Espoo | 549300V8QIWZML4PXR74 | 2016 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB SARL | France | RUEIL-MALMAISON | 549300TZFJYP8MMHV932 | 2016 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED | United Kingdom | UXBRIDGE | 5493001TSEVIRTZ8BR07 | 2016 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB A.E. | Greece | ATHENS | 549300ZB47B2UB9M2G32 | 2016 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY | Ireland | MULHUDDART | 5493005726ZQ17VEUV71 | 2019 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY | Ireland | DUBLIN | 549300EPKMFZ4TSMVS37 | 2022 | > 24 months |
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY | Ireland | DUBLIN | 5493008GEQ35GOVSEM62 | 2016 | lapsed > 24 months |
| SWORDS LABORATORIES | Ireland | MULHUDDART | 549300Z51ENH57RO4C59 | 2019 | lapsed > 24 months |
| BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED | India | MUMBAI | 3358006K289PUST68466 | 2025 | |
| BRISTOL-MYERS SQUIBB S.R.L. | Italy | ROME | 549300AC0905XNS34B76 | 2017 | > 24 months |
| BRISTOL-MYERS K.K. | Japan | SHINJUKU KU | 549300J3ZDVOKBM4JD31 | 2017 | lapsed > 24 months |
| Bristol-Myers Squibb de Mexico, S. de R.L. de C.V. | Mexico | Mexico City | 549300OQ2M2ZEVSPP145 | 2017 | lapsed > 24 months |
| Bristol-Myers Squibb Aktiebolag | Sweden | Solna | 54930017HG2FQTIQDW18 | 2016 | lapsed > 24 months |
| BMS FOREX COMPANY | United States | WILMINGTON | 549300Q7O3NKBHN0BP12 | 2022 | > 24 months |
| BMS STRATEGIC PORTFOLIO INVESTMENTS HOLDINGS, INC. | United States | WILMINGTON | 549300VHYW6QM3HGRK83 | 2022 | > 24 months |
| CELGENE ALPINE INVESTMENT CO., LLC | United States | WILMINGTON | 549300U6T7ETBRMG2U50 | 2021 | lapsed > 24 months |
| CELGENE KAPPA HOLDINGS LLC | United States | WILMINGTON | 549300NLN3GEBI8WPP35 | 2021 | lapsed > 24 months |
| JUNO THERAPEUTICS, INC. | United States | WILMINGTON | 5493004CAOW3ZGG2CV25 | 2024 |